Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CTSO stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CTSO investment potential.

What is CTSO stock price today?

Get real-time CTSO stock price, historical data, and price charts on Financhill. Track CTSO performance with our advanced analysis tools.

Is CTSO a good investment?

Evaluate CTSO investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CTSO stock?

To buy CTSO stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CTSO?

View detailed market capitalization data and company valuation metrics for CTSO on our comprehensive analysis page.

What is the P/E ratio of CTSO?

Use our fundamental analysis tools to view CTSO P/E ratio and compare valuation metrics with industry peers.

What are CTSO earnings?

View CTSO earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

CytoSorbents Corp. 10K Form

Sell

CTSO
CytoSorbents Corp.

Last Price:

$0.74

Seasonality Move:

20.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-09	10Q	CTSO/CytoSorbents Corp. Quarterly
2023-08-01	10Q	CTSO/CytoSorbents Corp. Quarterly
2023-05-02	10Q	CTSO/CytoSorbents Corp. Quarterly
2022-11-03	10Q	CTSO/CytoSorbents Corp. Quarterly
2022-08-02	10Q	CTSO/CytoSorbents Corp. Quarterly
2022-05-03	10Q	CTSO/CytoSorbents Corp. Quarterly

Receive CTSO News And Ratings

See the #1 stock for the next 7 days that we like better than CTSO

CTSO Financial Statistics

Sales & Book Value

Annual Sales:	$35.6M
Cash Flow:	$-2.5M
Price / Cash Flow:	0
Annual Sales:	$0.14
Price / Book:	5.15

Profitability

EPS (TTM):	-0.18990
Net Income (TTM):	$-10.6M
Gross Margin:	$25.1M
Return on Equity:	-89.32%
Return on Assets:	-21.76%

CytoSorbents Corp. Earnings Forecast

Key CytoSorbents Corp. Financial Ratios

The Gross Profit Margin over the past 17 years for CTSO is 70.59%.
The Selling, General & Administrative Expenses for CTSO have been equal to 98.32% of Gross Profit Margin.
The Research & Development expenses have been 19.43% of Revenue.
The Net Earning history of CTSO is -58.21% of Total Revenues.
Per Share Earnings over the last 19 years have been positive in 10 years.

CytoSorbents Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NASDAQ
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	CTSO
CUSIP:	23283X
Website:	cytosorbents.com

Debt

Debt-to-Equity Ratio:	3.04
Current Ratio:	2.11
Quick Ratio:	1.49

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	46.83

CTSO Technical Analysis vs Fundamental Analysis